To evaluate the differential expressions of VIM-AS1 in diabetic complications, the expression levels of VIM-AS1 in plasma samples from DR group (n = 60), DN group (n = 60), DG group (n = 60), DU group (n = 60), T2D group (n = 60) and the control (n = 60) group were measured by qPCR. Here, VIM is linked to type 2 diabetes mellitus.